 |
|
Recent Trends of Helicobacter pylori Eradication Therapy: Focusing on First Line Treatment
Ki Bang Kim, Yong Sik Kim
Korean J Helicobacter Up Gastrointest Res. 2014;14(4):237-241. Published online 2014 Dec 10 DOI: https://doi.org/10.7704/kjhugr.2014.14.4.237
|
|
Citations to this article as recorded by
 High and Frequent Dose of Dexlansoprazole and Amoxicillin Dual Therapy for Helicobacter pylori Infections: A Single Arm Prospective Study
Hye Yoon Park, Eun Jeong Kang, Dong Gun Kim, Ki Ju Kim, Jin Woo Choi, Su Youn Nam, Yong Hwan Kwon, Hyun Seok Lee, Seong Woo Jeon
Korean Journal of Gastroenterology.2017; 70(4): 176. CrossRef Clinical Efficacy of Gemifloxacin-containing Triple Therapy for First-line Treatment ofHelicobacter pyloriInfection: A Pilot Study
Tae Jun Kim, Jeung Hui Pyo, Hyuk Lee, Yang Won Min, Byung-Hoon Min, Jun Haeng Lee, Jae J. Kim
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2017; 17(3): 132. CrossRef Recent First Line Eradication Rate ofHelicobacter pyloriInfection: Single Center Experience
Seung Min Shin, Yun Jeong Lim, Yeo Jin Yoon, Hyoun Woo Kang, Jae Hak Kim, Jun Kyu Lee, Moon-Su Koh, Jin Ho Lee
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2015; 15(2): 108. CrossRef Web Survey of Society Members' Recognition of Guidelines for the Diagnosis and Treatment ofHelicobacter pyloriInfection in Korea, 2013 Revised Edition
Hyun Joo Song, Ki-Nam Shim, Byung-Wook Kim
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2015; 15(2): 95. CrossRef Recent Update on Third-lineHelicobacter pyloriEradication
Ji Hyun Kim
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2015; 15(2): 89. CrossRef
|